SEC Form 4 · accession 0001144204-16-117388
Neurotrope, Inc. · NTRP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Joshua Silverman
Director
Period of report
Aug 4, 2016
Accepted (ET)
Aug 8, 2016 · 8:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001513856
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F3 | $0.60 | Aug 4, 2016 | A | 250,000 | A | — | Aug 4, 2026 | Common Stock | 250,000 | 250,000 | D |
| Stock Option (right to buy)F2,F3 | $0.60 | Aug 4, 2016 | A | 50,000 | A | — | Aug 4, 2026 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1These securities were issued in connection with the Reporting Person's appointment as a non-employee director to the Issuer's board of directors.
- F2These securities were issued in connection with the Reporting Person's services on the committees of the Issuer's board of directors.
- F3The stock options shall vest in equal installments as follows: 25% shall vest immediately upon the date of grant and 25% shall vest on each of the first, second and third anniversaries of the date of grant (assuming continued service through such date).